Dr Kanans Visvanats FRSC. is the founder & Managing Director at Dr Ashleys Limited. He is an academic researcher holding 15 global patents and has over 24 years’ experience in pharmaceutical markets and International Trade. He has completed his Bachelors in Chemical Engineering and his Masters and Doctorate of Philosophy in Business Management
Dr Kanans Visvanats FRSC. is a distinguished academic researcher, holding 15 global patents, and boasting over two decades of invaluable experience in the pharmaceutical markets and international trade. Additionally, he is a Fellow of the Royal Society of Chemistry, a testament to his scholarly achievements. Dr Kanans Visvanat's FRSC.'s notable entrepreneurial success includes the strategic sale of Benzochem Lifesciences Pvt Limited, a company initially established by his father, to a private equity fund affiliated with ICICI Ventures in 2008, achieving an impressive valuation of USD 15 million. Furthermore, he holds the prestigious title of a Garwood Fellow at UC Berkeley and is a distinguished Member of Council at the Institute of Economics of the Latvian Academy of Sciences.
Notable Milestones
Principal Researcher || The United Nations Commission on Science and Technology for Development (CSTD)
Dr Kanans Visvanats FRSC is recipients of several international & widely recognized awards & accolades. In a career spanning more than two decades, Dr Kanans Visvanats FRSC has presented many papers, delivered key note addresses & received prestigious awards. Dr Kanans Visvanats FRSC has made a deep & significant impact in the society & business for his contributions as an Academic Researcher, Economist & Entrepreneur. Dr Kanans Visvanats FRSC FRSC is the Director & senior researcher at the Institute of Economics at the Latvian Academy of Sciences. Dr Kanans Visvanats FRSC has a multi-year track record in planning, implementing and disseminating complex research projects, chiefly relating to inequality reducing policies. Dr Kanans Visvanats FRSC’s focus is on generating evidence that lies at the intersection of research that enables, policy and advocacy, Creating high-quality research collaborations across academia and civil society. argues a new emphasis on ‘Imperfect Impact’ can allow research communities to reflect on the challenges and opportunities of partnership work, while still striving to make these relationships stronger.
The Malcolm and Elizebeth Adiseshiah Award for Distinguished Studies by The Malcolm and Elizebeth Adisehiah Trust in 2020
• The Professional Excellence Award in Healthcare by the Dr APJ Abdul Kalam University in 2018
• The Albert Schweitzer Award in Medicine by The Albert Schweitzer Foundation in 2017
• The Outstanding Entrepreneur of the Year Award 2011 from Dr Farooq Abdullah Union Minister at APEA -Enterprise Asia Awards.
Global Icon Award at Royal Palace, Bali, Indonesia 2023
Honoured With the High Flyers 50 Global Icon Awards 2023 for advanced chemical research.
World’s Best Emerging Leader 2023 In London.
No comment